InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-08-13 00:00:00 ET · period of report 2024-08-09 · accession 0001628280-24-036947 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-08-13 2024-08-09 TDOC Nanis Nikolaos P. CTO M - OptEx — +568 73.8K +0.8% —
D 2024-08-13 2024-08-12 TDOC Nanis Nikolaos P. CTO S - Sale+OE $7.14 -206 73.6K -0.3% -$1,471
D 2024-08-13 2024-08-09 TDOC Nanis Nikolaos P. CTO M - OptEx $0.00 -568 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-09 M A 568 — 73,794 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2024-08-12 S D 206 $7.14 73,588 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2024-08-09 M D 568 $0.00 0 D — · — to — 568 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On August 10, 2021, the reporting person was granted 1,703 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.